{"id":"tp-55659","type":"article-newspaper","title":"Taysha Gene Therapies Posts Third-Quarter 2026 Loss of $0.10 Per Share","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/55659","datePublished":"2026-11-12T16:53:38.000Z","dateModified":"2026-11-12T16:53:38.000Z","language":"en","abstract":"The net loss per common share was the same on a basic and diluted basis.","section":"Business","references":[]}